Multimodal Imaging Market to Accumulate Value of US$ 3.7 Billion by 2030, Opines Fact.MR

The multimodal imaging systems market is now valued at US$ 2.7 billion, and it is predicted that demand will grow at a consistent CAGR of 4% from 2022 to 2030. The global multimodal imaging market is anticipated to grow to a value of US$ 3.7 billion by the end of 2032.

As imaging has been widely used in the diagnosis and treatment of many diseases in recent years, it has become an essential component of the healthcare sector. This is expected to positively impact the growth potential of the multimodal imaging market throughout the course of the projected period.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7787?AS

Top Companies In The Multimodal Imaging Systems

• Bruker Corp.
• Spectrum Dynamics Medical Inc.
• Nipro Corp.
• PerkinElmer Inc.
• Shanghai United Imaging Healthcare Co. Ltd.
• Engineering GmbH
• Koninklijke Philips NV
• Mediso Ltd.
• Canon Inc.
• Carl Zeiss AG
• MILabs BV
• MR Solutions Ltd.
• General Electric Co.
• Heidelberg
• Neusoft Medical Systems Co. Ltd.
• Siemens AG
• Topcon Corp.
• TriFoil Imaging

Key Takeaways from Market Study

• In 2022, the global multimodal imaging market is valued at US$ 2.7 billion.
• Demand for multimodal imaging is projected to increase at 4% CAGR over the next eight years.
• By the end of 2030, the market is estimated to account for a valuation of US$ 3.7 billion.
• Increasing incidence of chronic diseases such as cardiovascular disorders, cancers, etc., rising investments in the R&D sector, increase in healthcare expenditure, and rapid adoption of advanced medical imaging solutions are prime factors driving market growth.
• The multimodal imaging industry accounts for an 8% share in the global medical imaging marketplace.
• The United States market accounts for a valuation of US$ 750 million in 2022.
• Lack of skilled medical professionals and high costs of advanced multimodal imaging devices are expected to hamper market progress to some extent across the forecast period.

Competitive Landscape

Top companies in the multimodal imaging systems marketplace are focusing on product innovation and launches to advance their sales potential and gain a competitive advantage over other market players.

• In May 2022, FUJIFILM VisualSonics Inc., a leading provider of photoacoustic and high-frequency ultrasound imaging systems announced the launch of an ultra-high to low frequency ultrasound multi-modal imaging system. Vevo F2 was designed for preclinical usage and offers high-definition image processing and is way better than previous generations of this imaging system.

Winning Strategy

Multimodal imaging device manufacturers are expected to focus on product innovation and launch products that have advanced imaging capabilities. Mergers and acquisitions are expected to be a prime focus for established market players across the forecast period as they try to cement their position in the global multimodal imaging market landscape.

Growing use of multimodal imaging diagnostic procedures is being witnessed to identify and treat various chronic conditions such as cardiovascular disorders, cancers, neurological diseases, and ophthalmic disorders. Rising incidence of chronic obstructive pulmonary disorders (COPDs) is also a factor that is anticipated to uplift multimodal imaging system sales over the coming years.
Hyperspectral imaging and the use of artificial intelligence (AI) in diagnostic imaging are also expected to be areas of prime importance in the healthcare imaging industry going forward. The growing senescent population and rising investments in healthcare infrastructure development in developing countries are also expected to lead to increased shipments of multimodal imaging equipment as time goes by.

Industry Research Segmentation

• By Technology:

o PET/CT Systems
o SPECT/CT Systems
o PET/MR Systems
o OCT/Fundus Imaging Systems
o Others

• By Product:

o Equipment
o Reagents
o Software

• By Application:

o Brain & Neurology
o Cardiology
o Oncology
o Ophthalmology
o Other Applications

• By End User:

o Hospitals
o Diagnostic Imaging Centers
o Others

• By Region:

o North America
o Latin America
o Europe
o APAC
o MEA

The report will improve the revenue impact of businesses in various industries by:

• Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global market and offers solutions
• Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
• Helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising synergies for top players aiming to retain their leadership position in the market.
How can Fact.MR Make Difference?
• In-depth understanding of key industry trends shaping the present growth dynamics
• Offers value chain analysis and price trend analysis of various offering of competitors
• Offers data-drive decision to help companies decide strategies that need recalibration
• Offers insights into areas in research and development that should attract
• Identifies data outliers before your competitors

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7787?AS

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.

This release was published on openPR.